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Abstract
Background: During the last century, WHO led public health interventions that resulted in spectacular
achievements such as the worldwide eradication of smallpox and the elimination of malaria from the Western
world. However, besides major successes achieved worldwide in infectious diseases control, most elimination/control
programs remain frustrating in many tropical countries where specific biological and socio-economical features prevented
implementation of disease control over broad spatial and temporal scales. Emblematic examples include malaria, yellow
fever, measles and HIV. There is consequently an urgent need to develop affordable and sustainable disease control
strategies that can target the core of infectious diseases transmission in highly endemic areas.
Discussion: Meanwhile, although most pathogens appear so difficult to eradicate, it is surprising to realize that human
activities are major drivers of the current high rate of extinction among upper organisms through alteration of their
ecology and evolution, i.e., their “niche”. During the last decades, the accumulation of ecological and evolutionary studies
focused on infectious diseases has shown that the niche of a pathogen holds more dimensions than just the immune
system targeted by vaccination and treatment. Indeed, it is situated at various intra- and inter- host levels involved on very
different spatial and temporal scales. After developing a precise definition of the niche of a pathogen, we detail how
major advances in the field of ecology and evolutionary biology of infectious diseases can enlighten the planning and
implementation of infectious diseases control in tropical countries with challenging economic constraints.
Summary: We develop how the approach could translate into applied cases, explore its expected benefits and
constraints, and we conclude on the necessity of such approach for pathogen control in low-income countries.
Background
Successes and failures of pathogen control
On June 28th 2011, the Food and Agriculture Organization
for the United Nations (FAO) has officially announced the
eradication of rinderpest from the surface of the globe,
10 years after the last recorded case [1]. Thirty years had
passed since the previous, and then only, global eradication
of an infectious pathogen, namely the smallpox [2]. These
examples are the most striking in an array of spectacular
achievements of public health interventions coordinated by
WHO for the last 60 years. Indeed, numerous pathogens
have been eliminated in large areas, such as malaria [3]
and plague [4] in Western countries, or yellow fever in
Latin America [5].
Meanwhile, in many tropical countries, infectious
diseases continue to exert a major toll on human popu-
lations and directly contribute to poverty and economic
instability [6]. Pathogen richness is indeed generally
higher in the tropics than in temperate areas [7] and in
many cases, vector biodiversity further adds to the
complexity of the transmission system [8]. Emblematic
examples include malaria in Africa [9] where both the
parasite and its mosquito vector species have now deve-
loped high levels of resistance to the most widely used
drugs and insecticides, further jeopardizing control as well
as elimination efforts [10,11]. Yellow fever is another frus-
trating example where the pathogen remains endemic in
many countries [12] despite the availability of an easily
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deliverable (lyophilized) and affordable vaccine [13] and
because of uncontrolled sylvatic transmission cycles
[14] allowing virus maintenance In turn, the current
eradication campaign against poliomyelitis illustrates a
tradeoff between limited available economic resources
and their allocation to solve the myriad of problems that
conflict or post-conflict countries have to confront
without functioning governance and public administra-
tions [15]. Moreover, in Pakistan and Afghanistan, al-
though funding for polio eradication might not be an issue
owing to substantial input from international and non gov-
ernmental agencies, societal concerns about vaccination as
well as the circulation of vaccine-derived polio viruses may
represent the biggest roadblocks to successful eradication
[16,17]. Last but not least, the HIV pandemic, as well, still
defies efficient control because 80% of the infected individ-
uals live in countries where current antiretroviral therapies
remain prohibitively expensive [18].
These issues do not concern only elimination and eradi-
cation programs, but also public health strategies aiming at
reducing pathogen burden in general. Indeed, our current
world is increasingly interconnected [19,20] and thus,
failures to manage local epidemics may rapidly convert into
global threats, as demonstrated by the SARS, Chikungunya,
H5N1 and H1N1 pandemics [21-23] during the last decade
and currently by H7N9 [24]. There is thus an urgent
need to explore new approaches for the development
of affordable and sustainable disease control tools and
strategies applicable on a global scale and particularly
in low-income countries.
Discussion
Whereas most pathogens appear so difficult to control,
to eliminate and/or to eradicate, evidence is accumula-
ting that human-induced environmental changes and
habitat destruction impact the ecology and evolution of
upper organisms and thus contribute significantly to the
current high rate of extinction [25]. Today, it is largely
accepted that an alteration of the niche of a species
(i.e., its position relative to available resources and
competitors present in the environment) is an efficient
driver to extinction if the species cannot evolve fast
enough to fill another niche or to adapt to the altered
one (e.g., 82% of endangered bird species are weakened
by niche alteration, especially habitat loss [26]). From
this perspective, recent advances in ecology and evolu-
tionary biology of pathogens [27-31] provide unprece-
dented opportunities to build on a new paradigm in the
way pathogen control is being devised and implemented.
By promoting research for manipulation of pathogens
niche as an efficient and effective means for their control,
we advocate the application, in public health, of the
opposed methodologies usually envisioned to rescue en-
dangered species in order to reach the opposite target of
conservation biology, i.e., the extinction (or eradication
as it is often referred to in epidemiology). Then, we call for
integrating disease control within a broader perspective,
focusing on the reverse conservation biology of pathogens.
What is a pathogen niche?
Ecological niche is a key concept in ecological literature,
for which many different definitions can be considered
[32,33]. From a very general point, we can define the niche
of an organism as the position of this organism within its
environment, available resources and competitors. Then, it
is characterized by all the conditions required to sustain a
viable population of the organism, in space and time. For
instance, the “fundamental” niche of African lions contains
grasslands and savannah prairies (their habitats) as well as
wildebeest and zebras (their resources). However, African
lions “share” their habitats and their resources with other
predators such as hyenas or wild dogs, yielding a “realized”
niche that is the “fundamental” one constrained by the
presence of competitors.
Then, pathogens, just like any organism, may have a
realized and a fundamental niche [34]. Since we aim at
applying pathogens niche manipulation to propose new
strategies in public health, all the potential resources
and interactions have to be considered. During the last
decades, the accumulation of ecological and evolutionary
studies focusing on infectious diseases has shown that
the niche of a pathogen holds more dimensions than just
the host immune system targeted by vaccination. More
specifically, the niche of a pathogen encompasses diverse
intra- and inter-host levels (Figure 1). Consequently, its
boundaries and evolution will depend upon a number of
biotic and abiotic interactions that go far beyond competi-
tion for the resource in susceptible hosts, the presence of
pathogens in the environment or the activation of the
immune system machinery in the host and/or the vector.
In many cases, human pathogens are also able to infect
and develop in other vertebrate hosts and most human in-
fectious diseases have a zoonotic transmission cycle [35],
in which the animal reservoir is fundamental to consider.
In addition, vector-borne pathogens do possess a required
step of development within their arthropod vector species
[36] while environmentally-transmitted pathogens may
persist during a significant period of time outside the
host [37]. Then, a pathogen may have biotic inter-
actions with many upper organisms and abiotic inter-
actions with environment outside the host, including
in the case of vector-borne diseases where the vector is
an ectotherm arthropod.
Within-host pathogen space is not that large either.
Evidences are accumulating that pathogens can compete
within the same host. This competition can take several
forms, through competition for resources such as red
blood cells between different species of Plasmodium [38]
Roche et al. BMC Public Health 2014, 14:753 Page 2 of 9
http://www.biomedcentral.com/1471-2458/14/753
or specialized cells within an organ like in the interaction
between influenza viruses and pneumococcal bacteria in
lungs [39]. Pathogens interactions are also mediated by the
immune system, such as in the case of malaria and
helminths [40] where each pathogen activates different and
inter-dependent immune paths (Th1 and Th2). It is also the
case for HIV that depresses the whole host immune system
therefore fostering the development of opportunistic infec-
tions, especially to Mycobacterium tuberculosis (TB) where
individuals infected by HIV are 20 to 30 times more likely
to develop an infection [41], a phenomenon enhanced by a
higher fatality rate during treatment of co-infected patients.
Finally, the within-host conditions also play an important
role [42], through for instance malnutrition [43] or vaccine
history that alters immune system efficiency [44].
The different layers that make up a pathogen’s niche,
involving various intra- and inter-host levels, impact the
infection process at two scales: host infection (colonization)
and within-host invasion (within-host pathogen replication).
Then, it follows that the initial and fundamental resource
for a pathogen is not only the availability of susceptible
hosts to infect but also the ability of hosts to sustain a
sizable pathogen load.
Public health strategies and pathogen’s niche: Applying
“reverse conservation biology” to pathogens
Classic control measures and pathogen’s niche
Following the above reasoning, most public health
strategies for pathogens control focuses on decreasing
the susceptible host population, especially through
prophylaxis (drugs or preventive vaccination). Figure 1
shows that this reduction results mainly from the tar-
geting of biotic interactions. Nevertheless, ecological
theory tells us that pathogen niche may also fluctuate
in space and time. Thus, this decrease in the susceptible
population can be organized more efficiently, by conside-
ring pathogen’s dynamics, i.e. its natural fluctuation in
space and time (Figure 2), opening opportunities to widen
the impact of preventive strategies while facilitating their
implementation through targeted actions in space and
time. This is already applied in some specific situations,
especially sporadic outbreaks of a threatening pathogen
such as meningitis [45], but this opportunity should be
considered for endemic pathogens as well.
How can the niche concept improve public health strategies
design and implementation?
Ecological and evolutionary literature on which the
niche concept relies is rich in lessons for devising and
combining public health strategies towards maximizing
their expected impact on pathogen transmission. A key
observation is that organism extinction usually stems
from the simultaneous alteration of several components
of its niche [46], such as resource availability [47] or
competition pressure [48]. This empirical and theoretical
framework, supported by many different kinds of organ-
isms [49-52] provides crucial insights to envision a new
paradigm in public health and infectious diseases ma-
nagement. Indeed, these results suggest that combining
public health measures that target different components
Figure 1 Different components of the niche of a human pathogen and how it can be used for its control. The green and blue boxes
represent resources and interactions situated at an inter- and intra-host level, respectively. The red boxes depict the main current methods used
in public health and their positive or negative impact on niche components (e.g., vaccination decreases number of susceptible individuals, and
increases population immunity).
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of a pathogen’s niche is expected to constrain more ef-
ficiently pathogen’s survival and transmission.
As a prerequisite to combining different strategies for
pathogens control in the field, one will need to assess
whether the effects of the different strategies applied at
the same time combine additively or not, in order to
identify the most relevant and synergistic combinations.
Moreover, when the net effect of strategies combination
is more than the simple addition of each strategy con-
sidered separately, the approach could be a very strong
asset for public health program management. Indeed,
with a given financial resource, it may be more efficient
to dedicate a proportion of this money to one control
measure, e.g., targeted vaccination, and the rest into an-
other control measure, such as vector control, rather
than 100% in either of the two. This clearly calls for
theoretical studies that will inform on the expected
outcomes of the different control methods, used alone
and in combination, as well as foster the development
of a modeling framework to identify the most suitable
strategies admixtures that will allow optimal efficiency
in terms of prevention and mitigation of infections.
Such modeling framework could benefit from the last
methodological developments in mathematical epidemi-
ology [30] and optimization theory [53].
Recent ecological knowledge relevant to public
health management?
Recent ecological and evolutionary studies of infectious
diseases have shed light on examples of pathogen niche
alteration with an impact on pathogen fitness, transmission
and/or virulence. For example, the presence of competing
pathogens is especially threatening for organism survival,
such as in the case of co-infection with Plasmodium
falciparum and helminths that can decrease malaria
severity in humans [54]. Similarly, maternally inherited
endosymbiotic bacterial Wolbachia infections were
shown to directly reduce the susceptibility of insects to
infection with a range of insect and human pathogens
[55], above and beyond their impact on vector’s life his-
tory traits relevant to vector capacity and transmission
(e.g., blood feeding frequency, longevity, fecundity…).
Niche alteration can also result from a temporary mis-
match between pathogens and hosts abundance. Many
pathogens reproduce at a given period of time when re-
sources are abundant and of good quality. It is known,
for instance, that apparent competition can take place
between two pathogens because one removes susceptible
hosts to the other one, such as in the case of measles and
whooping-cough [56]. This case definitely represents two
pathogens with a niche overlap.
Current control programs and the pathogen niche
approach: turning theory into practice
Current public health programs: where do we stand?
Current public health programs are highly heterogeneous
in their accounting for the multi-dimensionality of the
ecological niche of their target pathogens, ranging from
single specific approaches to integrated control initiatives.
Dengue and trachoma control are emblematic examples
of the extremes in this continuum. In the absence of a vac-
cine and efficient drugs, dengue control chiefly relies on
vector control, aiming at reducing mosquito abundance to
reduce disease transmission. On the other hand, the SAFE
WHO program [57], targeting the bacterium Chlamydia
trachomatis that causes trachoma uses a combination of
Figure 2 Examples of the evolution of a pathogen’s niche in space and time and how it can be manipulated for control. (Left )
Illustration of fluctuations in the number of susceptible and infectious individuals with time and an example of optimized pathogen control
combining pulsed vaccination of susceptible hosts and timely treatment of infectious ones. (Right) The host geographic structure can be used
and manipulated to stop a pathogen spill-over by restricting opportunities for migration between transmission hotspots where resources
(i.e., susceptible hosts) are plentiful.
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surgery, antibiotics, facial cleanliness and environmental
improvement to track the pathogen in different environ-
ments. However, it is estimated that dengue viruses still
infect around 100 million peoples each year [58]. Similarly,
18 million of active trachoma cases have been observed
in 2012 [59], highlighting that current public health
strategies can still be improved.
How can the pathogen niche approach improve current
public health programs?
The niche approach could improve public health pro-
grams implementation and strategy development in
several ways. First, as highlighted above for measles
[60] or polio [15], the majority of the current strategies
that mainly focus on one dimension of the pathogen
niche require highly effective and fast-acting control
tools, and a high coverage of target groups/populations.
This could be unrealistic is some settings (see above). In
this context, the ecological theory suggests the importance
of multiplying targets, rather than increasing selective
pressure on a single mechanism, in order to circumvent
the apparition of resistances. As an example, Dengue con-
trol mainly focuses on vector control while other strategies,
such as the use of Wolbachia that constrain virus develop-
ment in its mosquito vector or the currently-tested vaccine
are emerging and should prompt a new approach to den-
gue control programs in a near future. For diseases where
vaccine is the only control possibility, an immunization
strategy finely-tuned to the pathogen spatio-temporal
dynamics could still improve significantly its effectiveness.
First attempts considering only temporal dimension have
already shown the potential of such approach [61] and
should be extended to the spatial dimension, by focusing
on disease (or transmission) hotspots.
Second, for the current control strategies that already
focus on several targets within the pathogen’s niche, for
which the trachoma control program SAFE represents
an excellent example, a major insight from the pathogen’s
niche approach is the importance of considering the
temporal and spatial dimensions. Indeed, the necessity
to include spatio-temporal dynamics of pathogens to
understand local transmission, as well as efficiency of con-
trol programs, has been extensively demonstrated [62,63].
As previously exposed, the pathogen niche moves in space
and time. This implies that a period of time exists where
control could be most efficient, which generally precedes
the observation of optimal conditions for pathogen trans-
mission. As an example, if vector abundance presents a
seasonal pattern, it could be more efficient to enforce
vector control strategies when abundance is low as vector
populations might then be more amenable to control in
otherwise adverse environmental conditions.
Finally, ecological theory tells us that the evolutionary
dimension is also crucial to consider. The sequential
usage of different antibiotics (for trachoma) or insecticides/
larvicides (for dengue vectors) with different modes of
action for example, is an efficient way to reduce the risk
of emergence of resistance, and to mitigate its spread,
therefore promoting sustainability. The concept of Late-
Life-Acting insecticides i.e., compounds or organisms
that slowly kill the arthropod vector such that it dies
after reproduction but before it is able to transmit the
pathogen also directly stems from ecological and evolu-
tionary biology theory, and appears as a promising tool
for sustainable transmission control [64].
Moving from the concept of pathogen niche reduction
to implementation of a sustainable control strategy in
the field requires consolidated trans-disciplinary col-
laboration among scientists and will rely on endorse-
ment by all stakeholders at the political and societal
levels (e.g., disease control programs, ministries, tra-
ditional and state representatives,…). While modeling
will provide important insights to carefully tailor these
new public health strategies, current methods used in
public health, such as controlled field trials and careful
monitoring of epidemiological and ecological outcomes,
remain essential to validate models and set the ground for
scaling up. Moreover, in many cases implementation of
the niche reduction approach should build on existing
control programs and on strategies that are already imple-
mented in the field, and foster the development of truly
integrative control strategies that will take into account
the evolutionary dynamics of the pathogen.
Creating synergy from improvements produced by the
pathogen niche approach
While the benefits of using evolutionary theory to improve
current diseases control tools can be seen as intuitive and
are well-known to the public health community workers,
the major breakthrough due to the pathogen niche ap-
proach is synergy stemming from the combination of such
improvements, and the ability to capitalize on them. For
this to occur, careful tailoring of implementations in space
and time will be required. For example, identifying the key
period(s) and areas where different control methods should
be applied and combined with the highest expected efficacy
could be crucial for trachoma control, ensuring rational
control at the lowest cost.
A natural candidate disease for this approach could be
dengue. Indeed, a vaccine could be released reasonably
soon which targets a completely different compartment
of the virus niche than current vector control programs.
We are then in a context where combining vector control
and prophylactic drugs when vector abundance is low (i.e.,
either naturally, through seasonality of vector abundance or
artificially, through the use of vector control strategies) can
yield an extremely efficient pathogen control. The short
infectious period of dengue suggests that this combination
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has to be applied during a short period of time, which
is another benefit from this approach.
Control programs using pathogen niche in action:
success stories
An emblematic example of such concept in action is mal-
aria elimination in Italy during the first half of the twentieth
century [65]. Patients were mass-treated with chloroquine
during wintertime when mosquitoes can only survive
indoors and were therefore particularly amenable to
elimination through spraying of residual insecticides. In this
case, chloroquine has decreased abundance of susceptible
humans and insecticides have annihilated vector popula-
tions at a time when they were already at their nadir.
Another example of working strategies that target
different components of the pathogen’s niche is the case of
tri-therapies to treat HIV [18]. Indeed, patient well-being
has improved significantly in recent years thanks to the as-
sociation in a single treatment dose of different molecules
targeting different parts of the viral cycle, including pro-
tease inhibitors that block virus replication and reverse-
transcriptase inhibitors that constrain infections within cells.
Limitations and potential drawbacks of the pathogen
niche approach
The challenge of the niche approach implementation is
double. First, it relies on the availability of several control
tools with different targets that can be implemented to-
gether at the same time in the same place, or sequentially
in time and space. Pathogens and vectors are known to be
extremely plastic in their behavior with a high adaptive
potential. Failures in implementation or incorrect planning
might result in pathogen escape and niche shift with
unforeseen consequences for human health and the envi-
ronment. The second challenge therefore resides in the
ability of public health managers to act fast and imple-
ment several control strategies together locally, within a
short time-frame, but also to repeat such actions during
several years in order to ensure an efficient pathogen
control over the long-term. From the point of view of
economic resources, the costs can be decreased quite
significantly (lower level of drug use, less storage,
shortening the necessity of cold chain,…), but the logistics
and organization could be more complex to sort out.
These drawbacks are important and cannot be neglected.
They especially highlight that the niche approach should be
applied only to pathogens for which the ecological and
evolutionary dimensions are sufficiently documented and
achieved large scientific consensus.
Adopting a niche approach: a relevant thought for
pathogen control in low-income countries
We believe that the niche approach is particularly promis-
ing for countries with challenging economic constraints
where traditional approaches for diseases control could
not be implemented successfully and/or maintained
over time mainly due to financial shortcomings. Indeed,
as exemplified above, niche alteration has already been
successfully applied. Nevertheless, these first successes
are encouraging and clearly deserve to be continued in
this specific context of economic constraints. Moreover,
most of the pathogens affecting human populations are
now studied through the lens of ecology and evolution-
ary biology, extending dramatically the possibilities on
which public health strategies can rely. This new and
abundant literature documenting each part of the path-
ogen’s niche should now be integrated into policy decisions
on public health strategies.
The main benefit of such an approach is the opportunity
to shift from a public health strategy working on a long
time period to a public health strategy that targets specific
components of the disease system during a specific period
within a specific area. If we place this perspective in the
case of low-income and emerging countries where disease
elimination is not a priority, this approach can increase
political interest because it provides opportunities to
(i) decrease the cost of such public health programs
and (ii) the period of time where some infrastructures
have to be activated.
Thus, carefully tailoring public health interventions to
the pathogen niche may provide opportunities for im-
proving their success by enhancing control effectiveness
while maintaining low cost. We believe that mathemat-
ical modeling, extensively used into the study of ecology
and evolution of infectious diseases to connect theo-
retical mechanisms and observed patterns, is a privileged
tool to design innovative strategies finely tuned to diffe-
rent pathogens. If such low-cost solutions, direly needed
in economically constrained countries, can be identified
and proved successful from both a theoretical and
applied standpoint, it could be extended to other parts
of the World and applied at a global scale.
Summary
In public health, it is sometimes better to do nothing
than just a little
In resource-poor settings, public health officers may only
have access to a limited arsenal and supplies for diseases
control such as curative treatment, or prophylactic mea-
sures (e.g., vaccines, antibiotics or Insecticide Treated Nets).
Pursuing the goal of protecting local populations according
to the protocols used in the developed world, officers may
use available resources with poor efficacy and no clear
assessment of the consequences. For example, inappro-
priately managed, vaccination against childhood diseases
may be detrimental in the long term because it may
postpone the mean age of infection to age classes where
the disease is more severe. An example stemming from
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the history of malaria control is the poor management
of therapy (e.g., chloroquine) and/or insecticides (e.g., DDT
and pyrethroids) that yielded widespread resistance in most,
if not all, major African countries.
But doing nothing is never acceptable
Infectious diseases control must be applied globally,
including in resource-poor countries. Ecological and
evolutionary theories can inform Public Health and
policy makers on which component(s) of the pathogen’s
niche are the most appropriate and promising targets
(Figure 3). Grand strategies of how to impact on the
pathogen niche in various ways simultaneously should
be investigated in the light of financial constraints and
potential negative consequences for pathogen niche
shifts and public health. Combining recent advances in
mathematical modeling of infectious diseases, operational
research and financial optimization methodologies,
scientists would arm public health practitioners to
prepare effective and realistic solutions.
It is worth pointing out that ecological niche theory
is not the only concept from ecology and evolutionary
biology that may help envision innovative public health
strategies. For instance, invasion biology [66], explo-
ring specific traits that lead species to become invasive
or pests, might provide relevant insight and foster the
development of a suitable conceptual framework for
devising strategies aiming at preventing novel pathogens
emergence and spread, especially during this current era
of emerging and re-emerging infections [67]. Despite
developing such ideas is outside the scope of this paper,
we believe that such translation of ecological and evolu-
tionary concepts into public health should become a
research priority.
The approach should cause a paradigm shift in public
health, since we argue that a strong, but short, control
program does not fit with low-income countries settings.
Instead, altering the pathogen’s niche, i.e., changing
significantly its environment in a permanent way, can
lead to a better control in the long term. Moreover, it
has been suggested that pathogen elimination in large
territories are generally stable over time, i.e., a patho-
gen that has been eliminated does not easily re-emerge
[68]. Then, while classical tools such as drugs, therapies or
vaccines are definitely required to fight these pathogens,
using them within a pathogen’s niche approach should
allow a sustainable pathogen control in those specific
areas, increasing the probability of elimination.
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Figure 3 Envisioned benefits of the pathogen niche approach. Public health strategies are generally conditioned by an economic constraint
in low-income countries whereas they target maximal burden alleviation for high-income countries. Methods for pathogen control are known to
make things worse than doing nothing if coverage is below a given threshold (e.g., insufficient vaccine uptake against childhood infections
may postpone infections to teenage years when the disease has higher morbidity). Combining different methods for pathogen control
(e.g., vaccination tuned along the spatio-temporal dynamics of the pathogen in addition to quarantine) can decrease the risk of unexpected
backfires of public health programs and offer greater public health benefits for similar cost.
Roche et al. BMC Public Health 2014, 14:753 Page 7 of 9
http://www.biomedcentral.com/1471-2458/14/753
Received: 21 March 2014 Accepted: 17 July 2014
Published: 25 July 2014
References
1. Mariner JC, House JA, Mebus CA, Sollod AE, Chibeu D, Jones BA, Roeder PL,
Admassu B, vant ‘t Klooster GGM: Rinderpest eradication: appropriate
technology and social innovations. Science 2012, 337(6100):1309–1312.
2. Goodman R, Foster K, Trowbridge F, Figueroa J: Global disease elimination
and eradication as public health strategies. WHO Bulletin 1998, 76(S2):1–160.
3. Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, Smith DL,
Abeyasinghe RR, Rodriguez MH, Maharaj R, Tanner M, Targett G:
Operational strategies to achieve and maintain malaria elimination.
Lancet 2010, 376(9752):1592–1603.
4. Oldstone MBA: Viruses, Plagues and History. Oxford: Oxford Univeristy Press; 1998.
5. Soper FL: The elimination of urban yellow fever in the Americas through
the eradication of Aedes Aegypti. Am J Public Health 1964, 53(1):7–17.
6. Jamison D, Breman J, Measham A, Alleyne G, Claeson M, Evans D, Jha P,
Mills A, Musgrove P: Disease Control Priorities in Developing Countries. 2nd
edition. World Bank: Washington (DC); 2006.
7. Guernier V, Hochberg M, Guegan JF: Ecology drives the worldwide
distribution of human diseases. PLoS Biol 2004, 2(6):e141.
8. Fontenille D, Simard F: Unravelling complexities in human malaria
transmission dynamics in Africa through a comprehensive knowledge of
vector populations. Comp Immunol Microbiol Infect Dis 2004, 27:357–375.
9. Litsios S: Malaria control, the cold war, and the postwar reorganization of
international assistance. Med Anthropol 1997, 17(3):255–278.
10. Trape J, Pison G, Preziosi M: Impact of chloroquine resistance on malaria
mortality. C R Acad Sci III 1998, 321:689–697.
11. White N: Antimalarial drug resistance and mortality in falciparum
malaria. Trop Med Int Health 1999, 4:469–470.
12. Barnett ED: Yellow fever: epidemiology and prevention. Clin Inf Dis 2007,
44:850–856.
13. Monath TP: Yellow fever vaccine. Expert Rev Vaccines 2005, 4:553–574.
14. Wolfe ND, Dunavan CP, Diamond J: Origins of major human infectious
diseases. Nature 2007, 447:279–283.
15. Aylward B, Tangermann R: The global polio eradication initiative: lessons
learned and prospects for success. Vaccine 2011, 29:D80–D85.
16. Callaway E: Polio clings on in Pakistan. Nature 2011, 473:427–428.
17. Grassly NC, Fraser C, Wenger J, Deshpande JM, Sutter RW, Heymann DL,
Aylward RB: New strategies for the elimination of polio from India.
Science 2006, 314(5802):1150–1153.
18. Moore RD: Cost effectiveness of combination HIV therapy: 3 years later.
Pharmacoeconomics 2000, 17(4):325–330.
19. Tatem AJ, Hay SI: Climatic similarity and biological exchange in the
worldwide airline transportation network. Proc Biol Sci 2007,
274(1617):1489–1496.
20. Watts DJ, Strogatz SH: Collective dynamics of “small-world” networks.
Nature 1998, 393(6684):440–442.
21. Brownstein JS, Wolfe CJ, Mandl KD: Empirical evidence for the effect of
airline travel on inter-regional influenza spread in the United States.
PLoS Med 2006, 3(10):e401.
22. Colizza V, Barrat A, Barthelemy M, Valleron AJ, Vespignani A: Modeling the
worldwide spread of pandemic influenza: baseline case and
containment interventions. PLoS Med 2007, 4(1):e13.
23. Grais RF, Ellis JH, Glass GE: Assessing the impact of airline travel on the
geographic spread of pandemic influenza. Eur J Epidemiol 2003,
18(11):1065–1072.
24. Mei Z, Lu S, Wu X, Shao L, Hui Y, Wang J, Li T, Zhang H, Wang X, Yang F, Jin
J, Zhang Y, Zhang W: Avian influenza A(H7N9) virus infections, Shanghai.
China Emerg Infect Dis 2013, 19(7):1179–1181.
25. Chiras DD: Environmental Science (Action for a Sustainable Future).
Cummings Pub: New York City; 1994.
26. Temple SA: The problem of avian extinctions. Ornithology 1986, 3:453–485.
27. Collinge SH, Ray C: Disease Ecology: Community Structure and Pathogen
Dynamics. Oxford: Oxford University Press; 2006.
28. Grenfell BT, Dobson AP: Ecology of Infectious Diseases in Natural Populations.
Cambridge: Cambridge University Press; 1995.
29. Grenfell BT, Pybus OG, Gog JR, Wood JLN, Daly JM, Mumford JA, Holmes EC:
Unifying the epidemiological and evolutionary dynamics of pathogens.
Science 2004, 303(5656):327–332.
30. Keeling MJ, Rohani P: Modeling Infectious Diseases in Humans and Animals.
Princeton University Press: Princeton; 2008.
31. Lloyd-Smith JO, George D, Pepin KM, Pitzer VE, Pulliam JRC, Dobson AP,
Hudson PJ, Grenfell BT: Epidemic dynamics at the human-animal
interface. Science 2009, 326:1362–1367.
32. Begon M, Townsend CR, Harper JL: Ecology: From Individuals to Ecosystems.
4th edition. Cambridge: Blackwell Publishing; 2006.
33. Putman RJ: Community Ecology. New York: Springer; 1994.
34. Fodor E: Ecological niche of plant pathogens. Ann Forest Res 2011, 54(1):3–21.
35. Taylor LH, Latham SM, Woolhouse ME: Risk factors for human disease
emergence. Philos Trans R Soc Lond B Biol Sci 2001, 356(1411):983–989.
36. Gratz N: Vector- and Rodent-borne Diseases in Europe and North America:
Distribution, Public Health Burden and Control. Cambridge: Cambridge
University Press; 2006.
37. Walther BA, Ewald PW: Pathogen survival in the external environment and
the evolution of virulence. Biol Rev Camb Philos Soc 2004, 79(4):849–869.
38. McQueen PG, McKenzie FE: Competition for red blood cells can enhance
Plasmodium vivax parasitemia in mixed-species malaria infections.
Am J Trop Med Hyg 2006, 75(1):112–125.
39. Shrestha S, Foxman B, Weinberger DM, Steiner C, Viboud C, Rohani P:
Identifying the interaction between influenza and pneumococcal
pneumonia using incidence data. Sci Transl Med 2013, 5:191ra84.
40. Nacher M: Worms and malaria: resisting the temptation to generalize.
Trends Parasitol 2006, 22(8):350–352.
41. Crampin AC, Glynn JR, Traore H, Yates MD, Mwaungulu L, Mwenebabu M,
Chaguluka SD, Floyd S, Drobniewski F, Fine PEM: Tuberculosis transmission
attributable to close contacts and HIV status, Malawi. Emerg Infect Dis
2006, 12(5):729–735.
42. Flint PL, Franson JC: Does influenza A affect body condition of wild
mallard ducks, or vice versa? Proc Biol Sci 2009, 276(1666):2345–2349.
43. Chandra R: Nutrition and the immune system: an introduction. Am Journ
Clin Nutri 1997, 122:460–463.
44. Arinaminpathy N, Ratmann O, Koelle K, Epstein S, Price G, Viboud C, Miller
MA, Grenfell B: Impact of cross-protective vaccines on epidemiological
and evolutionary dynamics of influenza. Proc Natl Acad Sci U S A 2012,
109(8):3173–3177.
45. Pourbohloul B, Meyers LA, Skowronski DM, Krajden M, Patrick DM, Brunham
RC: Modeling control strategies of respiratory pathogens. Emerg Infect Dis
2005, 11(8):1249–1256.
46. Colwell RK, Fuentes ER: Experimental studies of the Niche. Ann Rev Ecol
Evol Syst 1975, 6:281–310.
47. Cornwell WK, Grubb PJ: Regional and local patterns in plant species
richness with respect to resource availability. Oikos 2003, 100(3):417–428.
48. Roughgarden J: Competition and theory in community ecology.
Am Nat 1983, 122(5):583–601.
49. Cardillo M, Mace GM, Jones KE, Bielby J, Bininda-Emonds ORP, Sechrest W,
Orme CDL, Purvis A: Multiple causes of high extinction risk in large
mammal species. Science 2005, 309(5738):1239–1241.
50. Ceballos G, Ehrlich PR, Elrich PR: Global mammal distributions,
biodiversity hotspots, and conservation. Proc Natl Acad Sci U S A 2006,
103(51):19374–19379.
51. Pimm S, Raven P, Peterson A, Sekercioglu CH, Ehrlich PR: Human impacts
on the rates of recent, present, and future bird extinctions. Proc Natl
Acad Sci U S A 2006, 103(29):10941–10946.
52. Rohr JR, Raffel TR, Romansic JM, McCallum H, Hudson PJ: Evaluating the
links between climate, disease spread, and amphibian declines.
Proc Natl Acad Sci U S A 2008, 105(45):17436–17441.
53. Forster GA, Gilligan CA: Optimizing the control of disease infestations at
the landscape scale. Proc Natl Acad Sci U S A 2007, 104(12):4984–4989.
54. Kwiatkowski D, Sambou I, Twumasi P, Greenwood BM, Hill AVS, Manogue
KR, Cerami A, Castracane J, Brewste DR: TNF concentration in fatal
cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum
malaria. Lancet 1990, 336(8725):1201–1204.
55. Hedges LM, Brownlie JC, O’Neill SL, Johnson KN: Wolbachia and virus
protection in insects. Science 2008, 322(5902):702.
56. Rohani P, Green CJ, Mantilla-Beniers NB, Grenfell BT: Ecological interference
between fatal diseases. Nature 2003, 422(6934):885–888.
57. West SK: Blinding trachoma: prevention with the safe strategy.
Am J Trop Med Hyg 2003, 69(Suppl 5):18–23.
58. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Farlow
AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF,
Roche et al. BMC Public Health 2014, 14:753 Page 8 of 9
http://www.biomedcentral.com/1471-2458/14/753
George DB, Jaenisch T, Wint GRW, Simmons CP, Scott TW, Farrar JJ, Hay SI:
The global distribution and burden of dengue. Nature 2013,
496(7446):504–507.
59. WHO: Global WHO Alliance for the Elimination of blinding trachoma by
2020. Wkly Epidemiol Rec 2012, 17:161–168.
60. Levin A, Burgess C, Garrison LP, Bauch C, Babigumira J, Simons E, Dabbagh
A: Global eradication of measles: an epidemiologic and economic
evaluation. J Infect Dis 2011, 204(Suppl 1):S98–S106.
61. Agur Z, Cojocaru L, Mazor G, Anderson RM, Danon YL: Pulse mass
measles vaccination across age cohorts. Proc Natl Acad Sci U S A 1993,
90(24):11698–11702.
62. Bolker BM, Grenfell BT: Impact of vaccination on the spatial correlation
and persistence of measles dynamics. Proc Natl Acad Sci U S A 1996,
93(22):12648–12653.
63. Earn DJ, Rohani P, Bolker BM, Grenfell BT: A simple model for complex
dynamical transitions in epidemics. Science 2000, 287(5453):667–670.
64. Michalakis Y, Renaud F: Evolution in vector control. Nature 2009, 462:298–300.
65. Snowden FM: The Conquest of Malaria: Italy, 1900–1962. New Hevean:
Yale University Press; 2006.
66. Shea K, Chesson P: Community ecology theory as a framework for
biological invasions. TREE 2002, 17:170–176.
67. Morens DM, Folkers GK, Fauci AS: The challenge of emerging and re-emerging
infectious diseases. Nature 2004, 430(6996):242–249.
68. Chiyaka C, Tatem AJ, Cohen JM, Gething PW, Johnston G, Gosling R,
Laxminarayan R, Hay SI, Smith DL: The stability of malaria elimination.
Science 2010, 339:909–910.
doi:10.1186/1471-2458-14-753
Cite this article as: Roche et al.: The niche reduction approach: an
opportunity for optimal control of infectious diseases in low-income
countries?. BMC Public Health 2014 14:753.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Roche et al. BMC Public Health 2014, 14:753 Page 9 of 9
http://www.biomedcentral.com/1471-2458/14/753
